Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results
Boston Scientific (NYSE: BSX) will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026, with CEO Mike Mahoney and Dr. Janar Sathananthan in a 50-minute Q&A at ~8:00 a.m. ET.
Rhea-AI Summary
Boston Scientific (NYSE: BSX) will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026, with CEO Mike Mahoney and Dr. Janar Sathananthan in a 50-minute Q&A at ~8:00 a.m. ET. The company will webcast its Q2 2026 earnings call on July 29, 2026 at 8:00 a.m. ET, hosted by Mike Mahoney and CFO Jon Monson. A news release with Q2 results will be issued prior to the call, and live webcasts plus replays will be available at the company's investor site approximately one hour after each event.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BSX
On May 4, the day this news came out, BSX closed 0.62% above the previous close.
Data tracked by StockTitan Argus for the May 4 session.
Key Figures
- Bernstein Q&A duration
- 50 minutes
- Question-and-answer session length at Bernstein’s 42nd Annual Strategic Decisions Conference
- Bernstein session time
- 8:00 a.m. ET
- Start time for conference Q&A on May 27, 2026
- Q2 2026 call time
- 8:00 a.m. ET
- Start time for Q2 2026 results conference call on July 29, 2026
- Quarter end date
- June 30, 2026
- End date for the second quarter 2026 being discussed on the call
Previous Conferences,earnings Reports
-
Announced webcast to discuss Q1 2026 financial results and highlights.
-
Outlined J.P. Morgan conference participation and Q4/FY 2025 earnings call date.
-
Scheduled 2025 Investor Day and Q3 2025 earnings conference call webcasts.
-
Set timing for Q2 2025 results call with webcast and replay details.
-
Announced Q1 2025 results call and webcast access information.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Additionally, the company will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2026, on Wednesday, July 29, 2026, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney and Jon Monson, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the second quarter 2026 on July 29 prior to the conference call.
A live webcast and replay for each event will be accessible at https://investors.bostonscientific.com. The replays will be available approximately one hour following the completion of each event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-bernsteins-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results-302760793.html
SOURCE Boston Scientific Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.